Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial

Comparison of GeneXpert MRSA/SA ETA assay with semi-quantitative and quantitative cultures and nuc gene-based qPCR for detection of Staphylococcus aureus in endotracheal aspirate samples

(2019) Jasmine Coppens et al.   Antimicrobial Resistance and Infection Control

Penetration of a Monoclonal Antibody Combination (ASN100) Targeting S. aureus Cytotoxins in Lung Epithelial Lining Fluid: A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study in Healthy Volunteers.

(2019) Zoltan Magyarics et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest

(2019) Bruno François et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial

(2018) Bruno François et al.   INTENSIVE CARE MEDICINE

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia

(2017) Antoni Torres et al.   EUROPEAN RESPIRATORY JOURNAL

Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults

(2016) Xiang-Qing Yu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public–Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia: Table 1.

(2016) Bruno François et al.   CLINICAL INFECTIOUS DISEASES

Ultra short course antibiotics for patients with suspected ventilator-associated pneumonia but minimal and stable ventilator settings

(2016) Michael Klompas et al.   CLINICAL INFECTIOUS DISEASES

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

(2016) Andre C. Kalil et al.   CLINICAL INFECTIOUS DISEASES

Molecular quantification of bacteria from respiratory samples in patients with suspected ventilator-associated pneumonia

(2016) M. Clavel et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014

(2016) Lindsey M. Weiner et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013

(2016) Mark L. Metersky et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mechanisms of Neutralization of a Human Anti-α-toxin Antibody

(2014) Vaheh Oganesyan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Assessment of an Anti-Alpha-Toxin Monoclonal Antibody for Prevention and Treatment of Staphylococcus aureus-Induced Pneumonia

(2013) L. Hua et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Staphylococcus aureus Induces Eosinophil Cell Death Mediated by α-hemolysin

(2012) Lynne R. Prince et al.   PLoS One

Alpha-Toxin Induces Programmed Cell Death of Human T cells, B cells, and Monocytes during USA300 Infection

(2012) Tyler K. Nygaard et al.   PLoS One

Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment

(2012) Gilles Capellier et al.   PLoS One

Functional Antibodies Targeting IsaA ofStaphylococcus aureusAugment Host Immune Response and Open New Perspectives for Antibacterial Therapy

(2010) Udo Lorenz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ventilator‐Associated Pneumonia: The Clinical Pulmonary Infection Score as a Surrogate for Diagnostics and Outcome

(2010) Marya D. Zilberberg et al.   CLINICAL INFECTIOUS DISEASES

Economic Burden of Ventilator-Associated Pneumonia Based on Total Resource Utilization

(2010) Marcos I. Restrepo et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

A European care bundle for prevention of ventilator-associated pneumonia

(2010) Jordi Rello et al.   INTENSIVE CARE MEDICINE